Table 2.

The correlations between plasma adiponectin concentration and metabolic syndrome (MS) markers.

	0•12 weeks		0•18 weeks		12•18 weeks
	EG (n = 8)	CG (n = 7)	EG (n = 8)	CG (n = 7)	EG (n = 8)	CG (n = 7)
΢ Weight (kg)	•0.322	•0.105	0.148	•0.433	0.179	•0.198
΢ BMI (kg/m2)	•0.196	•0.023	0.099	•0.362	0.218	•0.394
΢ Waist circumference (cm)	0.189	0.035	0.154	•0.398	0.262	0.110
΢ SBP (mmHg)	0.560	0.048	•0.074	•0.012	•0.167	•0.159
΢ DBP (mmHg)	0.376	0.067	•0.142	•0.614	0.335	0.745
΢ BFM (kg)	•0.415	•0.595	0.128	•0.561	•0.489	•0.323
΢ PBF (%)	•0.330	•0.732	0.252	•0.462	•0.717*	•0.327
΢ LBM (kg)	0.157	0.534	0.005	0.088	0.792*	0.167
΢ Percentage of lean body (%)	0.315	0.733	•0.270	0.476	0.732*	0.315
΢ TG (mg/dL)	0.591	•0.264	0.628	0.013	•0.531	•0.594
΢ HDL-C (mg/dL)	•0.064	•0.247	•0.252	•0.406	0.281	•0.117
΢ Blood glucose (mg/dL)	•0.376	•0.528	•0.183	•0.717	•0.083	•0.710
΢ Insulin (α/4IU/mL)	•0.075	0.313	0.295	0.763	•0.750*	0.425
΢ HOMA-IR index	•0.109	0.298	0.319	0.744	•0.728*	0.432

΢, baseline data minus data at 12 weeks and baseline data minus data at detraining (18 weeks) and 12 weeks data minus data at detraining (18 weeks).

* p < 0.05.

BFM, body fat mass; CG, control group; DBP, diastolic blood pressure; EG, exercise group; HDL-C, high density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment-insulin resistance; LBM, lean body mass; PBF, percentage of body fat; SBP, systolic blood pressure; TG, triglyceride.